Anti-influenza A virus restriction factors that shape the human species barrier and virus evolution
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
PLOS pathogens. - 19, 7 (2023) , e1011450, ISSN: 1553-7374
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2023
- Creator
- DOI
-
10.1371/journal.ppat.1011450
- URN
-
urn:nbn:de:bsz:25-freidok-2379067
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Petric, Philipp P.
- Schwemmle, Martin
- Graf, Laura Brigitte
- Universität
Time of origin
- 2023
Other Objects (12)
Development of a chimeric bat influenza A virus as a live vaccine
Bats reveal the true power of influenza A virus adaptability
Bat influenza viruses: insights in the molecular biology and characterization of infectious viruses
Adaptation von Influenza-A-Viren an den humanen Restriktionsfaktor MxA
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets
The influenza A virus genome packaging network - complex, flexible and yet unsolved
Unexpected functional divergence of bat influenza virus NS1 proteins
Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11
An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus
Poly-ADP ribosyl polymerase 1 (PARP1) regulates influenza A virus polymerase
Internal viral RNA sequences of the PB2 genome segment of influenza A virus are required for efficient generation of fully infectious particles
A modified live bat influenza A virus-based vaccine prototype provides full protection against HPAIV H5N1
Development of a chimeric bat influenza A virus as a live vaccine
Bats reveal the true power of influenza A virus adaptability
Bat influenza viruses: insights in the molecular biology and characterization of infectious viruses
Adaptation von Influenza-A-Viren an den humanen Restriktionsfaktor MxA
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets
The influenza A virus genome packaging network - complex, flexible and yet unsolved
Unexpected functional divergence of bat influenza virus NS1 proteins
Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11
An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus
Poly-ADP ribosyl polymerase 1 (PARP1) regulates influenza A virus polymerase
Internal viral RNA sequences of the PB2 genome segment of influenza A virus are required for efficient generation of fully infectious particles
A modified live bat influenza A virus-based vaccine prototype provides full protection against HPAIV H5N1
Development of a chimeric bat influenza A virus as a live vaccine
Bats reveal the true power of influenza A virus adaptability
Bat influenza viruses: insights in the molecular biology and characterization of infectious viruses
Adaptation von Influenza-A-Viren an den humanen Restriktionsfaktor MxA
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets
The influenza A virus genome packaging network - complex, flexible and yet unsolved
Unexpected functional divergence of bat influenza virus NS1 proteins
Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11
An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus
Poly-ADP ribosyl polymerase 1 (PARP1) regulates influenza A virus polymerase
Internal viral RNA sequences of the PB2 genome segment of influenza A virus are required for efficient generation of fully infectious particles